Recital 5, Regulation (EU) 2026/794

In forcesince 27 Mar 2026

In addition, the Annex to Commission Implementing Regulation (EU) 2018/1882 [Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the spread of those listed diseases (OJ L 308, 4.12.2018, p. 21, ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj).], as recently amended by Commission Implementing Regulation (EU) 2026/169 [Commission Implementing Regulation (EU) 2026/169 of 26 January 2026 amending the Annex to Implementing Regulation (EU) 2018/1882 concerning the categorisation of infection with bluetongue virus (serotypes 1-24) as a listed disease (OJ L, 2026/169, 27.1.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/169/oj).], re-categories infection with bluetongue virus (serotypes 1-24) as a category D+E disease, when it had previously been categorised as a category C+D+E disease. That amendment to Implementing Regulation (EU) 2018/1882 applies from 1 November 2026. As a consequence of such re-categorisation, the rules for infection with bluetongue virus (serotypes 1-24) relating to official disease-free status or to eradication programmes, including the requirements for movements of germinal products when entering into a disease-free Member State or zone thereof or into a Member State or zone thereof subjected to an eradication programme laid down in Part II, Chapter 2, Section 4, of Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).] and in Annex V, Part II, thereto, were amended by Commission Delegated Regulation (EU) 2026/797 [Commission Delegated Regulation (EU) 2026/797 of 27 March 2026 amending Delegated Regulation (EU) 2020/689 as regards the infection with bluetongue virus (serotypes 1–24) eradication programmes and disease-free status (OJ L, 2026/797, 7.8.2026, ELI: http://data.europa.eu/eli/reg_del/2026/797/oj).]. Those amendments to Delegated Regulation (EU) 2020/689 apply from 1 November 2026. Therefore, the requirements laid down in those provisions of Delegated Regulation (EU) 2020/689 related to the official disease-free status of a Member State or zone thereof or to carrying out an eradication programme for infection with bluetongue virus (serotypes 1-24) cease to apply from 1 November 2026. Accordingly, Annex II, Part 5, Chapter II, to Delegated Regulation (EU) 2020/686 should be amended by deleting the references to a disease-free status and to an eradication programme for that disease.